SK
Samatha Kantlala
About Samatha Kantlala
Data last updated:
Samatha Kantlala is a Director at Heka Pharma Private Limited (since 2023) and Director at Meliora Pharma (Opc) Private Limited (since 2022). The companies operate in Food And Beverages and Trading.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Heka Pharma Private Limited U24304TG2019PTC133997 | Director | 21 Apr 2023 | 2019 | Active | |
| Meliora Pharma (Opc) Private Limited U51909CH2022OPC044236 | Director | 08 Mar 2022 | 2022 | Active |
Board colleagues of Samatha Kantlala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sharanaiah | 08505742 | Heka Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samatha Kantlala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samatha Kantlala
Samatha Kantlala currently holds 2 directorships: Heka Pharma Private Limited (Director, since 21 Apr 2023); Meliora Pharma (Opc) Private Limited (Director, since 08 Mar 2022).
Samatha Kantlala was first appointed on 08 Mar 2022 as Director at Meliora Pharma (Opc) Private Limited. The most recent appointment on record is 21 Apr 2023 at Heka Pharma Private Limited.
The current boards of Samatha Kantlala's companies include Sharanaiah (Heka Pharma Private Limited).